Pfizer’s Bourla Bets His Pension on Company Stock as CEO Defends Drug Firm
“All my pension I put into Pfizer stock,” Bourla told Barron’s Editor at Large Andy Serwer on Monday, in a recording of At Barron’s on the sidelines of the World Economic Forum. “I’m all in.”
Regulatory filings with the Securities and Exchange Commission show that Bourla conducted an intra-plan transfer in his Supplemental Savings Plan pension for nearly 376,000 Pfizer units of so-called phantom stock in mid-December. The phantom units will be settled in cash at a price of $26.63 each—$10 million altogether—when Bourla leaves the company, and may be transferred by him into an alternative investment account at any time. The company confirmed the transaction was made with holdings from a pension fund of Bourla’s.
It’s a personal bet on Pfizer executing a turnaround—one that Bourla wants to oversee himself, as Wall Street raises questions over the future of his leadership.
"People are best convinced by reasons they discover themselves"
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.